Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MGNX
#3585
MacroGenics, Inc.
3.4
9
USD
+0.58%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.58%
Monthly Change
+15.18%
6 month change
+115.43%
Year Change
+166.41%
Previous Close
3.4
7
Open
3.4
9
Bid
Ask
Low
3.4
9
High
3.4
9
Volume
80
Markets
US Stock Market
Healthcare
MGNX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Market Capitalization
221.81 M
Employee
293
Founded
2000
CEO
N/A
Website
www.macrogenics.com
Headquarter
Delaware, United States
FIGI
BBG000BM2SF8
Industry
Technology
News
MacroGenics: Oncology Opportunities In Play, But Investing Feels Like A Gamble (MGNX)
MacroGenics at The Citizens Life Sciences Conference: Strategic Reemergence in 2026
MacroGenics at Leerink Global Healthcare Conference: Strategic Pipeline Focus
Stifel reiterates MacroGenics stock rating with $4 price target
MacroGenics Inc earnings missed by $0.03, revenue topped estimates
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates
Stifel reiterates Incyte stock rating after FDA setback
MacroGenics at TD Cowen Conference: Strategic Imperatives in Focus
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
MacroGenics stock falls after FDA places partial clinical hold
Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes